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Abstract
Background: Commercial diagnostics are commonly used to identify gram-positive bacteria.
Errors have been reported mostly at the species level. We have found certain phenotypic criteria
used in API systems which significantly misidentify Leuconostoc, an emerging human pathogen, at the
genus level. We also attempt to find practical, conventional phenotypic assays for accurate
identification of this group of bacteria.
Methods: Clinical isolates of catalase-negative, gram-positive coccoid or coccobacillary bacteria
with non-β hemolysis in our institute during 1997–2004 were subject to an identification aid by API
20 STREP, following the instruction manual, as an aid to conventional phenotypic tests. Those
identified as Leuconostoc by API 20 STREP were re-examined by the same kit and also by API 50
CHL according to the instruction manuals, by our Leuconostoc conventional phenotypic assays, by
Leuconostoc- and Lactobacillus-specific PCR's, and, where possible, by 16S rDNA sequence analysis.
In addition, catalase-negative gram-positive isolates during 2005–2006 which were resistant to
vancomycin at high levels were also evaluated by the same phenotypic and genotypic assays.
Results: Out of several thousands of clinical gram-positive isolates, 26 catalase negative gram-
positive isolates initially identified as Leuconostoc by API 20 STREP and 7 vancomycin-resistant gram-
positive catalase-negative bacteria entered the study. 11 out of the 26 isolates and all the 7 isolates
were identified as Leuconostoc by API 20 STREP. Only 5 isolates, however, were confirmed by both
genotypic and all defined conventional phenotypic criteria. API 50 CHL also failed to reliably
provide accurate identification of Leuconostoc. We have identified key problem tests in API 20
STREP leading to misidentification of the bacteria. A simple, conventional set of phenotypic tests
for Leuconostoc identification is proposed.
Conclusion: The current API systems cannot accurately identify Leuconostoc. Identification of
vancomycin-resistant, catalase-negative gram-positive bacteria should be performed by a few
practical phenotypic assays, with assistance of genotypic assays where available.
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Background
Leuconostoc is a gram-positive coccoid or coccobacillary
emerging human pathogen found in environment, foods
and food products [1]. Risk factors of infection include
antibiotic pressure, foreign device, or underlying immune
defects. The organism is naturally highly resistant to van-
comycin with MIC ≥ 256 µg/ml but could be successfully
treated with penicillin with MIC ranging from 0.25 to 1.0
unit/ml. Commercial diagnostics are commonly used to
identify gram-positive bacteria, with errors mostly at the
species level [2,3]. Here we report inaccuracies of the Ana-
lytical Profile Index systems (API 20 STREP and API 50
CHL, Biomérieux, Inc., Lyon, France) in identifying Leu-
conostoc  at the genus level. We also propose practical
methods for clinical bacteriology laboratories to identify
this organism.
Methods
Clinical isolates of catalase negative gram-positive coccoid
or coccobacillary pairs and chains with α- or γ-hemolysis
in our institute during 1997–2004 were subject to an
identification aid by API 20 STREP (bioMérieux, Inc.,
Lyon, France), following the instruction manual. Those
identified as Leuconostoc by API 20 STREP were re-exam-
ined by the same kit and by API 50 CHL (bioMérieux, Inc.,
Lyon, France) according to the instruction manuals, by
Leuconostoc conventional phenotypic assays, by Leuconos-
toc- and Lactobacillus-specific PCR's, and by 16S rDNA
sequence analysis as previously described [4]. The 800-bp
16S rDNA fragment corresponds to Escherichia coli posi-
tions 10 to 806. The sequencing results were compared
with those available in the GenBank, using BLASTN. Cri-
teria for our conventional phenotypic assays for Leuconos-
toc  are catalase-negative gram-positive coccoid or
coccobacillary bacteria evaluated after growth in thiogly-
colate broth at 35°C for 24–48 hours [5], vancomycin
MIC ≥ 256 µg/ml by Etest (AB BIODISK, Solna, Sweden),
CO2 production from glucose in de Man, Sharp, Rogosa
(MRS) broth (Difco, Detroit, MI, USA) with Durham
tubes and negative pyrrolidonyl arylamidase (PYR), leu-
cine arylamidase (LAP), and arginine dihydrolase (ADH)
[6]. Leuconostoc-specific PCR was performed on all isolates
as described [7], with slight primer modifications, as
stated below. These modifications were to make the
primer sequences most complementary and specific to
Leuconostoc  strains in GenBank. Forward and reverse
primer sequences were 5'-CACAGCGAAAGGTGCTT-
GCAC-3' and 5'-GATCCATCTCTAGGTGACGCC-3',
respectively. To further assess accuracy of the API 20
STREP kit, additional catalase-negative gram-positive coc-
coid or coccobacillary isolates during 2005–2006 with
vancomycin MIC ≥ 256 µg/ml were also evaluated by the
same phenotypic and genotypic assays (isolates 31–38 in
Table 1). Our gold standard for Leuconostoc identification
is that the organisms fulfill both conventional phenotypic
criteria and either or both of the genotypic assays (PCR
and 16S rDNA sequence analysis). As we suspected that
some isolates might have been Lactobacillus, also a lactic
acid bacteria with overlapping phenotypes, Lactobacillus-
specific PCR was also performed on all isolates as
described [8]. PCR using universal primers targeting bac-
terial 16S rRNA conserved sequences was also performed
to ensure template quality. The forward primer Y1 corre-
sponds to positions 20 to 43 in the E. coli 16S rRNA
sequence and the reverse primer Y2 corresponds to E. coli
positions 361 to 338 [9]; this protocol gave positive
results for all isolates in the study. Leuconostoc mesenter-
oides  ATCC 8293, Pediococcus pentosaceus ATCC 33316,
Lactobacillus pentosus ATCC 8041 and Lactobacillus
plantarum ATCC 14917 served as controls for all assays.
This study has been approved by The Institutional Review
Board of The Faculty of Medicine, Chulalongkorn Univer-
sity.
Results
Our clinical bacteriology laboratory has a busy service,
serving a 1,500-bed university hospital. Out of several
thousands of gram-positive bacteria isolated during
1997–2004, 26 catalase-negative gram-positive isolates
(isolates 1–26) were initially identified as Leuconostoc by
API 20 STREP. 7 catalase-negative gram-positive strains
with vancomycin MIC ≥ 256 µg/ml were isolated during
2005–2006 (isolates 31–33 and 35–38). Thus, 33 clinical
isolates entered the study. As 16S rDNA sequencing anal-
ysis was performed after the other tests, the results were
not complete. Some isolates could not be retrieved, and
some could not be amplified.
11 isolates of isolates 1–26 were reproducibly identified
by API 20 STREP as Leuconostoc (Table 1). Only 3 of the 11
isolates, however, were confirmed by both genotypic and
all defined phenotypic criteria (Table 1). 7 catalase-nega-
tive gram-positive isolates with vancomycin MIC ≥ 256
µg/ml (isolates 31–33 and 35–38) were all identified as
Leuconostoc by API 20 STREP, only 2 of which were con-
firmed genotypically. API 20 STREP identified Lactobacil-
lus pentosus ATCC 8041 and Pediococcus pentosaceus ATCC
33316 as Leuconostoc  with 81.1% and 39.3% identity,
respectively. Regarding all 31 non-leuconostoc strains
(including reference strains and clinical isolates), API 20
STREP identified 10 of them as Leuconostoc with over 90%
identity. 16S rDNA sequencing data were available in 7 of
the 10 isolates and all were closely-related Weissella spp. 6
isolates were read as Leuconostoc with 50–90% identity.
Two of these were Lactobacillus pentosus ATCC 8041 and
Lactobacillus salivarius (isolate 26) and two were Pediococ-
cus (isolates 35 and 38). API 50 CHL identified almost all
Leuconostoc correctly, at least to the genus level, except for
isolate 3. The kit, however, identified Pediococcus pen-
tosaceus ATCC 33316, 7 out of 8 Weissella spp., all 6 strep-B
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Table 1: Comparison of various identification methods for 4 ATCC reference strains of Lactobacillus, Pediococcus, Leuconostoc, and 26 catalase-negative, gram-positive clinical isolates from 
1997–2004 (numbers 1–26) initially identified as Leuconostoc by API 20 STREP or 7 isolates from 2005–2006 expressing high levels of vancomycin resistance (numbers 31–33 and 35–38).
Isolate #-specimen 
type
API 20 STREP (% 
identity)
API 50 CHL (% identity) Gram's 
staining results
ADH LAP MRS PYR Van PCR for Lactobacillus 
and Leuconostoc
Sequencing of 16S 
rDNA gene (% identity)
Lactobacillus plantarum 
ATCC 14917*
Enterococcus avium (63.2) Lactobacillus plantarum (99.9) B -/- +/+ - -/- R +ve Lactobacillus Lactobacillus plantarum (100)
Lactobacillus pentosus 
ATCC 8041*
Leuconostoc (81.1) Lactococcus lactis ssp lactis 1 (82.5) B -/- +/+ + -/- R +ve Lactobacillus N/A
Pediococcus pentosaceus 
ATCC 33316*
Leuconostoc (39.3) Lactobacillus pentosus (84.3) C +/+ +/+ - -/- R Neg Pediococcus pentosaceus 
(99.4)
Leuconostoc mesenteroides 
ATCC 8293
Leuconostoc (96.8) Leuconostoc mesenteroides ssp 
mesenteroides/dextranicum 1 (95.7)
Cb -/- -/- + -/- R +ve Leuconostoc Leuconostoc mesenteroides 
(99.3)
1-pus* Streptococcus suis biotype 
I (85.6)
Lactobacillus acidophilus (97.4) C-Ch -/+# +/-# -- / -S N e g Streptococcus suis (100)
2-blood* Leuconostoc (99.8) Lactococcus lactis ssp lactis 1 (90.5) Cb +/+ -/- + -/- R Neg N/A
3-corneal discharge Leuconostoc (97.9) Lactobacillus brevis 3 (98.8) C-Ch -/- -/- + -/- R +ve Leuconostoc N/A
4-ascitic fluid Leuconostoc (99.9) Leuconostoc mesenteroides spp 
mesenteroides/dextranicum 2 (99.9)
C -/- -/- + -/- R +ve Leuconostoc Leuconostoc lactis or 
garlicum (99.5)
5-ascitic fluid* Leuconostoc (93.6) Lactobacillus acidophilus 1 (85.1) Cb +/+ -/- + -/- R Neg N/A
6-blood Leuconostoc (95.4) Leuconostoc lactis (96.0) Cb -/- -/- + -/- R +ve Leuconostoc Leuconostoc lactis or 
garlicum (99.6)
7-blood Leuconostoc (68.5) Leuconostoc lactis (92.0) Cb -/- -/- + -/- R Neg N/A
8-blood* Streptococcus mitis 1 
(81.1)
Lactobacillus acidophilus (92.1) Cb -/- +/-# -- / -S N e g N / A
9-blood* Leuconostoc (97.2) Leuconostoc mesenteroides spp 
cremoris (99.9)
Cb +/+ -/- + -/- R Neg Weissella cibaria (100)B
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10-blood* Abiotrophia adiacens 
(46.9) Aerococcus viridans 
2 (27.5)
Lactobacillus delbrueckii spp 
delbrueckii (78.1)
Cb -/- -/- - -/- S Neg N/A
11-blood* Leuconostoc (92.2) Lactobacillus acidophilus (72.5) C-Ch -/- -/+# -- / -S N e g N / A
12-ascitic fluid* Lactococcus lactis spp 
cremoris (47.2) 
Leuconostoc (45.1)
Lactobacillus salivarius (99.9) C-Ch -/- -/- - -/- R +ve Lactobacillus N/A
13-blood* Streptococcus sanguis 
(49.2) other streptococci 
(48.5)
Leuconostoc mesenteroides spp 
cremoris (98.7)
Cb -/- +/-# -- / -S N e g N / A
14-blood* Leuconostoc (39.0) 
Lactococcus lactis ssp 
cremoris (37.9)
Lactobacillus acidophilus 1 (88.2) C -/- -/+# -- / -S N e g Streptococcus pasteurianus 
(99.9)
15-blood* Streptococcus bovis (64.8) Leuconostoc lactis (87.9) Cb -/- +/-# -- / - R N e g Weissella confusa (99.9)
16-blood* Enterococcus faecium 
(98.7)
Lactobacillus plantarum 1 (98.6) Cb +/+ +/-# -+ / - # SN e g Enterococcus faecium (99.9)
17-blood* Aerococcus viridans (62.6) Lactobacillus delbrueckii spp 
delbruekii (95.5)
Cb -/- -/- - -/- S Neg Actinomyces odontolyticus 
(98.9)
18-brain abscess* Streptococcus constellatus 
(99.9)
Lactobacillus acidophilus (82.1) C-Ch +/+ +/-# +- / -S N e g Streptococcus anginosus or 
constellatus (99.7)
19-blood* Streptococcus bovis 
biotype II (64.8)
Lactobacillus acidophilus 1 (98.1) C-Ch -/- +/-# +- / -S N e g Streptococcus constellatus 
(99.7)
20-blood* Leuconostoc (92.2) Weissella viridescens (99.8) C -/+# -/+# -- / - R N e g Weissella viridescens (99.9)
21-lung swab* Leuconostoc (99.9) Lactobacillus acidophilus (78.4) Cb +/+ -/- + -/- R Neg Weissella cibaria (100)
22-bone* Leuconostoc (99.6) Lactobacillus coprophilus (96.9) Cb +/+ -/- + -/- R Neg Weissella confusa (99.61)
23-NR* Leuconostoc (98.8) Lactobacillus coprophilus (96.9) Cb +/+ -/+# -- / + # RN e g Weissella confusa (100)
Table 1: Comparison of various identification methods for 4 ATCC reference strains of Lactobacillus, Pediococcus, Leuconostoc, and 26 catalase-negative, gram-positive clinical isolates from 
1997–2004 (numbers 1–26) initially identified as Leuconostoc by API 20 STREP or 7 isolates from 2005–2006 expressing high levels of vancomycin resistance (numbers 31–33 and 35–38). B
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24-NR* Aerococcus viridans (48.5) 
Lactococcus lactis ssp 
cremoris (41.6)
Leuconostoc mesenteroides spp 
cremoris (94.7)
C-Ch -/+# +/-# -- / -S N e g Streptococcus anginosus 
(99.9)
25-pus* Streptococcus constellatus 
(99.9)
Lactobacillus delbrueckii (80.4) C-Ch +/+ +/-# -- / -S N e g Streptococcus constellatus 
(99.7)
26-duodenal* content Leuconostoc (89.9) Lactobacillus salivarius (99.9) Cb -/- +/-# - -/- R +ve Lactobacillus Lactobacillus salivarius (100)
31-urine* Leuconostoc (99.7) Lactobacillus acidophilus 1 (49.5) Cb +/+ -/- + -/- R Neg Weissella cibaria (99.5)
32-gastric content Leuconostoc (99.4) Leuconostoc lactis (95.3) C-Ch -/- -/- + -/- R +ve Leuconostoc Leuconostoc garlicum or 
lactis (99.2)
33-tissue biopsy Leuconostoc (99.9) Leuconostoc mesenteroides spp 
mesenteroides/dextranicum2 (99.9)
C-Ch -/- -/- + -/- R +ve Leuconostoc Leuconostoc garlicum or 
lactis (99.6)
35-ascitic fluid* Leuconostoc (65.8) Pediococcus pentosaceus 1 (63.6) C -/- +/+ - -/- R neg Pediococcus stilesii (91.5)
36-blood Leuconostoc (92.8) Lactobacillus collinoides or 
fermentum 1 (98.3)
Cb -/- -/- + -/- R neg Weissella confusa (99.9)
37-pleural fluid* Leuconostoc (69.2) Lactobacillus salivarius (99.9) Cb -/- +/+ - -/- R neg N/A
38-tissue biopsy* Leuconostoc (82.7) Pediococcus pentosaceus (99.9) C +/+ +/+ - -/- R neg Pediococcus pentosaceus 
(98.2)
ADH = arginine dihydrolase, LAP = leucine arylamidase, MRS = gas production in MRS broth, PYR = pyrrolidonyl arylamidase test, Van = vancomycin MIC; S = MIC in the range of 0.5–1.0 µg/ml; R = MIC ≥ 
256 µg/ml NR = no record available, N/A = result not available. ADH, LAP, and PYR test results listed are from API 20 STREP and from conventional phenotypic assays, respectively. Discordant results 
between the two methods are marked with #. In Gram's staining results column, C = cocci, Cb = coccobacillary form, C-Ch = cocci in chain, B = bacilli. * = phenotype(s) opposite to what is (are) expected 
for Leuconostoc in our criteria above. API 20 STREP identifies Leuconostoc at the genus level only. PCR results are indicated as positive for Leuconostoc or Lactobacillus or negative for both protocols. 16S rDNA 
sequencing results are indicated together with % similarity to the closest GenBank sequences.
Table 1: Comparison of various identification methods for 4 ATCC reference strains of Lactobacillus, Pediococcus, Leuconostoc, and 26 catalase-negative, gram-positive clinical isolates from 
1997–2004 (numbers 1–26) initially identified as Leuconostoc by API 20 STREP or 7 isolates from 2005–2006 expressing high levels of vancomycin resistance (numbers 31–33 and 35–38). BMC Infectious Diseases 2007, 7:69 http://www.biomedcentral.com/1471-2334/7/69
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tococci, and 1 Enterococcus  as either Lactobacillus  or
Leuconostoc. Of all 37 standard and clinical strains, 14
demonstrated at least one discrepant biochemical test
results between API 20 STREP and manual phenotypic
assays (Table 1). All these belonged to non-leuconostoc
isolates and do not affect conventional phenotypic inter-
pretation of these isolates as non-leuconostoc. Identity
percentages given by API 20 STREP and API 50 CHL had
poor correlations with PCR or phenotypes.
With regard to the 7 isolates of catalase-negative gram-
positive bacteria with high-level vancomycin resistance
which were all identified as Leuconostoc by API 20 STREP,
only 2 of them were confirmed as such by genotypic
assays. API 50 CHL correctly identified both isolates as
Leuconostoc, one of which was correct at the species level.
Discussion
Commercial diagnostics have been widely used in bacteri-
ology laboratories to identify common organisms, such as
Streptococcus, to the species level, or to identify unusual
gram-positive organisms in clinical specimens, e.g. Aero-
coccus, Lactobacillus, and Leuconostoc, among others. Stud-
ies illustrating inaccurate identification of various gram-
positive pathogens have been published [3,10-14]. In this
study, our purpose is to raise an awareness that Leuconos-
toc, an emerging human pathogen, can be overdiagnosed
by certain commercial diagnostics.
Occasional discrepant results among the same biochemi-
cal tests obtained from API 20 STREP and from manual
conventional assays are not unexpected, as incomplete
agreement of various automated and manual systems
have been reported [15-17]. Reproducibility of API 20
STREP for Leuconostoc identification is only moderate in
our study. Previous studies have shown higher consist-
ency of bacterial identification by commercial diagnostics
[18,19]. Clinical isolates in our study were initially identi-
fied during the time spanning from 1997–2006 and thus
repeated API 20 STREP testing was done months or years
thereafter. Our lower reproducibility could be, at least
partly, due to loss or change in some characteristics by
repeated subculture [20,21].
All 6 standard and clinical Leuconostoc strains were cor-
rectly identified by API 20 STREP and 5 by API 50 CHL, at
least at the genus level. On the contrary, specificity of Leu-
conostoc identification by these API kits were only moder-
ate at best. As evidenced by 16S rDNA sequence analysis,
most of the isolates misidentified as Leuconostoc by API
systems were in the genus Lactobacillus  and  Weissella,
which are closely-related bacteria, followed by Pediococcus,
also one of the lactic acid bacteria [6]. API 20 STREP failed
to identify these isolates obviously because Lactobacillus
and  Weissella  are not listed in the Identification Table
[22]. Even some strains of streptococci and enterococci
initially were identified as Leuconostoc. Streptococcus con-
stellatus isolate 19 was misidentified at the species level.
API 50 CHL misidentified most Weissella  in this study
obviously because only one species, Weissella viridescens, is
included in the Identification Table of the kit.
Our conventional phenotypic criteria correlated well with
Leuconostoc-specific PCR and 16S rDNA sequence analysis
in almost all isolates, except for isolates 7 and 36 (Table
1). Isolate 7 was phenotypically compatible with Leucon-
ostoc but negative by PCR. This could be closely-related
bacteria which are certain lactobacilli such as L. sanfran-
cisco, or L. fructosus, or Weissella [23], or some rare Leucon-
ostoc  not detected by our PCR protocol. Weisella  is a
recently-described genus found in a variety of foods. Some
of its members used to be Leuconostoc paramesenteroides
and heterofermentative lactobacilli. Reliability of the con-
ventional phenotypic criteria in this study is evidenced by
the fact that only 1 of the 8 Weissella isolates and none of
the 2 Lactobacillus isolates (one identified by 16S rDNA
sequencing and both by PCR) was misidentified as Leu-
conostoc.
The importance of accurate identification of Leuconostoc
also needs to be emphasized in the clinical arena. Case
reports based on incomplete and/or inappropriate pheno-
typic criteria with or without assistance of commercial
diagnostics are subject to potential errors [24-27], given
the fact that Leuconostoc and related bacteria possess over-
lapping phenotypes. Flawed clinical reports include an
incorrect argument that heterofermentative Lactobacillus
must hydrolyze arginine [25], while in fact L. sanfrancisco
and L. fructosus do not [23], and labeling the organism as
Leuconostoc even though the organism was LAP positive
[26].
Two major limitations of API 20 STREP are noted. Firstly,
the test contains Leuconostoc in its list, while some other
medically-important lactic acid bacteria with overlapping
phenotypes such as Lactobacillus, Weissella and Pediococcus,
are not included. It is of note, however, that, according to
the manufacturer, Leuconostoc is a multiple taxon of Leu-
conostoc and Lactobacillus and if a strain is identified as Leu-
conostoc, a note "POSSIBILITY OF Lactobacillus  spp" is
included in the report. Considering Leuconostoc as a mul-
tiple taxon of Leuconostoc and Lactobacillus by the manu-
facturer is not very practical, as Leuconostoc  and
Lactobacillus are distinct bacteria, microbiologically and
clinically. Given that human infections by these lactic acid
bacteria are emerging, these organisms could obviously be
misidentified as Leuconostoc by API 20 STREP, potentially
contributing to cumulative incorrect reporting in medical
literature and incorrect understanding of its clinical spec-
tra and epidemiology. Secondly, while clinical isolates ofBMC Infectious Diseases 2007, 7:69 http://www.biomedcentral.com/1471-2334/7/69
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Leuconostoc, as a rule, are LAP and ADH negative, the test
lists Leuconostoc as 70% LAP and 10% ADH positive [22].
Appropriate modifications of the kit criteria for Leuconos-
toc would significantly enhance its accuracy. For clinical
laboratories, we propose that all catalase-negative gram-
positive coccoid or coccobacillary bacteria with high level
of vancomycin resistance (MIC ≥ 256 µg/ml) be tested
with the manual phenotypic assays listed in Table 1:
Gram's staining of the isolate grown in thioglycolate
broth, arginine dihydrolase (ADH), leucine arylamidase
(LAP), gas production in MRS broth, and pyrrolidonyl
arylamidase (PYR) test. Users of this method are to accept
that, even though more accurate than the current API sys-
tems, these conventional assays could still occasionally
misidentify certain lactobacilli and Weissella as Leuconos-
toc. This practical guide should minimize avoidable inac-
curate identification of this emerging pathogen.
Conclusion
The current API systems, similar to some other commer-
cial identification systems for microorganisms, still need
improvement before they can reliably identify certain
unusual gram-positive pathogens. They lack specificity in
Leuconostoc identification. We propose that, for accuracy
and reliability, identification of vancomycin-resistant, cat-
alase-negative gram-positive bacteria be performed by
practical, conventional phenotypic assays, with assistance
of a genotypic confirmation where available.
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